RNA sequencing (RNA-seq) using next-generation sequencing gives scientists information on both the nucleotide sequences and the quantity of RNA transcripts in a sample. Two common approaches are mRNA sequencing (mRNA-seq) and total RNA-seq. Each yields different information at the end of the experiment, and one may suit a given sample type better than the other. Researchers therefore need to understand their research question and sample limitations at the outset to choose the most appropriate method.
Start down the right library prep path
The key difference between mRNA-seq and total RNA-seq is the material that gets sequenced, and that choice is made during library prep. “The library-preparation strategy determines which biological signals are preserved and therefore influences what can be measured reliably downstream,” says Naira Movsisyan, Senior Product Manager at Novogene Europe.
mRNA-seq
mRNA-seq works on polyadenylated (poly(A)) eukaryotic transcripts, which must first be enriched from the starting material.1 This is most often accomplished using oligo-dT primers attached to magnetic beads. The primers anneal 3′ poly(A) tails, allowing those transcripts to be isolated, converted to cDNA, and sequenced. Non-poly(A) transcripts are lost in the process, so the library contains mostly mature protein-coding mRNAs, along with certain polyadenylated long noncoding RNAs (lncRNAs). In standard mRNA-seq, the enriched nucleic acids are fragmented before sequencing, so reads cover the full length of each transcript.
Because mRNA makes up only a small fraction of total RNA, enrichment focuses sequencing reads to the transcripts that matter most for gene expression studies. mRNA-seq typically requires fewer reads per sample compared to total RNA-seq, so several mRNA libraries can be sequenced for the cost of one total RNA-seq library. The method has drawbacks, however: the enrichment steps can introduce bias, and it performs poorly with degraded samples where poly(A) tails may not be intact.
Total RNA-seq
Total RNA-seq measures gene and transcript abundance plus noncoding RNA (ncRNA), taking researchers beyond gene expression. Ribosomal RNA (rRNA) makes up the majority of RNA in a cell, so it is first depleted by hybridization with sequence-specific probes to improve sensitivity, which is particularly important when the transcripts of interest are expressed at low levels.2 Everything that remains is sequenced, including pre-mRNAs, mRNAs, and ncRNAs such as lncRNAs. Random primers produce cDNA from both coding and noncoding RNAs, covering transcripts without bias toward the 5′ or 3′ end.
Beyond expression levels, total RNA-seq provides information on regulatory regions, exon–intron boundaries, and antisense RNAs. Because it retains nascent and intronic RNA, Movsisyan explains, it can also reveal how an expression state was generated through transcription and RNA processing. Total RNA-seq works with fragmented or degraded RNA, including FFPE samples, but it needs more sequencing data than mRNA-seq, which raises costs.
Matching the method to the research question
“mRNA-seq and total RNA-seq are best suited to different research objectives because they profile different RNA populations,” says Deyra Rodríguez, Product Marketing Manager at New England Biolabs. “The choice comes down to which RNA populations are needed to answer the biological question.”
“mRNA-seq is well suited for focused analysis of protein-coding gene expression, particularly differential expression, pathway analysis, and transcript-level changes,” says Cissy Jiang, Global Product Manager at Bio-Rad Laboratories. “Examples include comparing tumor versus normal tissue, measuring treatment-induced gene-expression changes, or profiling developmental states.” The method is also higher throughput, making it attractive for studies with larger sample numbers.
Total RNA-seq is the better fit for studying transcriptional regulation, RNA processing, transcript discovery, and host-pathogen interactions. Noncoding RNAs are increasingly appreciated for what they reveal about cellular states.3,4 Jiang adds that total RNA-seq suits “investigating stress or disease-associated transcriptome changes, profiling degraded or archival samples, or discovering previously uncharacterized transcripts and RNA populations.”
Some workflows capture certain RNA classes better than others, so researchers whose questions span several of these may need to combine library preparation approaches.2
The right method for the sample
“Researchers often think they are choosing a sequencing strategy. In reality, the sample is frequently making part of that decision for them,” says Rodríguez.
For mammalian samples, Jiang notes, mRNA-seq is best suited to high-quality RNA when the main goal is measuring protein-coding gene expression. Bacterial mRNAs typically lack poly(A) tails, so poly(A)-based mRNA-seq is not appropriate in this case, and total RNA-seq with rRNA depletion is commonly used instead. Degraded and FFPE samples also point toward rRNA depletion, because fragmentation limits poly(A) recovery.
Some samples pose problems for both methods. “Whole blood presents a separate problem: globin transcripts are both poly(A) and extremely abundant, so they consume sequencing capacity in poly(A)-selected and rRNA-depleted libraries alike,” says Movsisyan. The table below summarizes how common sample types influence the choice.
| Sample or situation | Usually favors | Why |
|---|
| High-quality eukaryotic RNA, coding-gene focus |
mRNA-seq |
Reads concentrate on protein-coding transcripts |
| Large sample numbers or screens |
mRNA-seq or 3′-end counting |
Lower sequencing needs per sample |
| Bacteria |
Total RNA-seq (rRNA depletion) |
mRNAs lack stable poly(A) tails |
| Viral RNA or host-pathogen studies |
Total RNA-seq |
Key transcripts may lack poly(A) tails |
| Degraded, FFPE, or archival samples |
Total RNA-seq |
Fragmentation limits poly(A) recovery |
| Very low input or small biopsies |
Often rRNA depletion |
Input limits narrow options |
| Whole blood |
Either, plus globin depletion |
Globin transcripts consume reads in both |
| Non-model organisms |
Total RNA-seq, with validated depletion |
Depletion chemistry varies by species |
Trade-offs: where to spend your reads
“The main trade-off is essentially breadth versus focus,” says Jiang. “While mRNA-seq provides a focused view of protein-coding transcripts and can deliver efficient mRNA sequencing, it can miss important non-polyadenylated RNA populations.”
Total RNA-seq casts a wider net, but its reads are spread across more types of RNA. Achieving comparable coverage of protein-coding genes may therefore require greater sequencing depth, more complex analysis, and higher costs, Rodríguez explains. “A broader view is not always a better view,” she says. “Every read devoted to one RNA population is a read that cannot be spent elsewhere.”
For very large studies, Movsisyan points to a further option: high-throughput 3′-end mRNA-seq approaches, which sequence only a short region of each transcript, often using unique molecular identifiers. These work well for large perturbation or drug-screening studies but sacrifice information about alternative splicing and transcript structure. “The best strategy is therefore the one that captures enough information to answer the biological question without generating additional complexity that the study will not use,” she says.
Jiang offers a rule of thumb: “If you primarily want to understand what genes are being expressed differently, then mRNA-seq is a strong choice, but if you want to understand the broader RNA landscape and how it may be regulated, total RNA-seq simply gives you that additional biological insight that may be key.”
Future perspectives
The experts agree that both methods have their place. Both will become more sensitive and streamlined as technologies advance, and Rodríguez expects to see researchers use mRNA-seq and total RNA-seq more often as complementary strategies within the same study. Lower input requirements and better compatibility with lower-quality samples will make it easier for scientists to find a workflow tailored to their biological questions.
Jiang indicates that more sensitive and efficient sequencing will improve the ability to capture a broad range of RNA species from low-input or degraded samples, while advances and automation in library preparation, sequencing, and analysis should make these broader approaches more accessible.
Movsisyan sees new value in total RNA data. “Intronic and nascent RNA that was once treated mainly as background is increasingly becoming useful for studying transcription and RNA processing,” she says. Total RNA approaches are also expanding into single-cell analysis. Long-read, direct RNA, single-cell, and spatial technologies will add further layers of information, such as transcript isoforms, native RNA features, cellular identity, and tissue context, but Rodríguez expects them to complement mRNA-seq and total RNA-seq rather than replace them.
“The future is not one RNA-seq method that does everything,” says Rodríguez. “It is a more flexible set of tools where the choice is informed by the biological question, rather than the limitations of the sample or workflow.”
References
1. Stark R, et al. RNA sequencing: the teenage years. Nature Reviews Genetics. 2019;20(11):631-656.
2. Hrdlickova R, et al. RNA ‐Seq methods for transcriptome analysis. Wiley Interdisciplinary Reviews - RNA. 2016;8(1).
3. Nemeth K, et al. Non-coding RNAs in disease: from mechanisms to therapeutics. Nature Reviews Genetics. 2023;25(3):211-232.
4. Gao Y, et al. Recent advances in investigation of circRNA/lncRNA-miRNA-mRNA networks through RNA sequencing data analysis. Briefings in Functional Genomics. 2025;24.